Surfactant Protein D as a Biomarker for Chronic Obstructive Pulmonary Disease

References

• Mannino DM, Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ 2002; 51(6):1–16.
   Google Scholar
• Sorensen GL, Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 2006; 290(5):L1010–1017.
   PubMed Web of Science ®Google Scholar
• Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005; 5(1):58–68.
   PubMed Web of Science ®Google Scholar
• McCormack FX, Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 2003; 278(38):36250–36256.
   PubMed Web of Science ®Google Scholar
• Wu H, Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003; 111(10):1589–1602.
   PubMed Web of Science ®Google Scholar
• LeVine AM, Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001; 167(10):5868–5873.
   PubMed Web of Science ®Google Scholar
• LeVine AM, Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000; 165(7):3934–3940.
   PubMed Web of Science ®Google Scholar
• Ohya M, Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide. Biochemistry 2006; 45(28):8657–8664.
   PubMed Web of Science ®Google Scholar
• Yamazoe M, Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors. J Biol Chem 2008; 283(51):35878–35888.
   PubMed Web of Science ®Google Scholar
• Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res 2008; 57(11):497–503.
   PubMed Web of Science ®Google Scholar
• Numata M, Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc Natl Acad Sci USA 2010; 107(1):320–325.
   PubMed Web of Science ®Google Scholar
• Kuronuma K, Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J Biol Chem 2009; 284(38):25488–25500.
   PubMed Web of Science ®Google Scholar
• Ishii T, Involvement of surfactant protein D in emphysema revealed by genetic association study. Eur J Hum Genet 2012; 20(2):230–235.
   PubMed Web of Science ®Google Scholar
• Guo X, Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001; 18(3):482–490.
   PubMed Web of Science ®Google Scholar
• Ishii T, Association between genetic variations in surfactant protein d and emphysema, interstitial pneumonia, and lung cancer in a Japanese population. COPD 2012.
   PubMedGoogle Scholar
• Foreman MG, Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2011; 44(3):316–322.
   PubMed Web of Science ®Google Scholar
• Hersh CP, Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005; 33(1):71–78.
   PubMed Web of Science ®Google Scholar
• Finley TN, Ladman AJ. Low yield of pulmonary surfactant in cigarette smokers. N Engl J Med 1972; 286(5):223–227.
   PubMed Web of Science ®Google Scholar
• Honda Y, Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996; 109(4):1006–1009.
   PubMed Web of Science ®Google Scholar
• Betsuyaku T, Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Eur Respir J 2004; 24(6):964–970.
   PubMed Web of Science ®Google Scholar
• More JM, Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm Med 2010; 10:53.
   PubMed Web of Science ®Google Scholar
• Schmekel B, Recoveries of phosphatidylcholine and alveolar macrophages in lung lavage from healthy light smokers. Clin Physiol 1991; 11(5):431–438.
   PubMedGoogle Scholar
• Mutti A, Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest 2006; 129(5):1288–1297.
   PubMed Web of Science ®Google Scholar
• Lomas DA, Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 2009; 34(1):95–102.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kanoh S, Motoyoshi K. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking. Biomarkers 2008; 13(4):385–392.
   PubMed Web of Science ®Google Scholar
• Sin DD, The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177(11): 1207–1214.
   PubMed Web of Science ®Google Scholar
• Winkler C, Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res 2011; 12:29.
   PubMed Web of Science ®Google Scholar
• Ju CR, Liu W, Chen RC. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease. Dis Markers 2012; 32(5):281–287.
   PubMed Web of Science ®Google Scholar
• Duvoix A, Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD. COPD 2011; 8(2):79–95.
   PubMedGoogle Scholar
• Tkacova R, Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D. Med Sci Monit 2010; 16(11):CR540–544.
   Google Scholar
• Sin DD, Pahlavan PS, Man SF. Surfactant protein D: a lung specific biomarker in COPD? Ther Adv Respir Dis 2008; 2(2):65–74.
   PubMedGoogle Scholar